Osteoarthritis

Session Type: ACR Study Groups
Tuesday, November 8, 2011: 1:00 PM-2:00 PM
W195 (McCormick Place West)

Session Overview:
The pathogenesis of primary osteoarthritis is still not well understood. Significant advances have been made in the role of alterations in chondrocyte behavior in the osteoarthritis disease process but this has not yet led to a functional pharmalogical therapy. However, since the chondrocyte is considered a major player in primary osteoarthritis, elucidation of the triggers that control chondrocyte behavior is of utmost importance to develop adequate osteoarthritis treatments.

Upon completion of this session, participants should be able to:

  • discuss the role of the chondrocyte in the osteoarthritis disease process
  • discuss the role of articular chondrocyte hypertrophy in osteoarthritis development and progression

Talks:
1:00 PM
Peter Van Der Kraan, University Hospital Nijmegen, Nijmegen, Netherlands
1:05 PM
Of Mice and Men: Is Chondrocyte Hypertrophy a Driving Force in OA Initiation or Progression?
Mary Goldring, Hospital for Special Surgery/Weill Cornell Med Col, New York, NY
1:30 PM
Cartilage Degradation in OA Results From Loss of ALK-1 Mediated Chondrogenesis and Induction of ALK5-Mediated Joint Tissue Fibrosis
Anna H. Plaas, Rush University, Chicago, IL
See more of: ACR Study Groups

To see other sessions for this day, use the date buttons to the left.